US Bancorp
DAWN

US Bancorp’s Day One Biopharmaceuticals DAWN Stock Holding History

US Bancorp’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.88K Buy
414
+150
+57% +$2.11K ﹤0.01% 3393
2025
Q4 		$2.46K Hold
264
– – ﹤0.01% 3720
2025
Q3 		$1.86K Buy
264
+240
+1,000% +$1.65K ﹤0.01% 3766
2025
Q2 		$156 Buy
24
+4
+20% +$28 ﹤0.01% 4091
2025
Q1 		$159 Sell
20
-550
-96% -$5.92K ﹤0.01% 4102
2024
Q4 		$7.22K Buy
+570
New +$7.93K ﹤0.01% 3536
2023
Q2 		– Sell
-22,265
Closed -$298K – 4021
2023
Q1 		$298K Buy
+22,265
New +$435K ﹤0.01% 1681

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

US Bancorp's DAWN Position: Q1 2026 in Review

US Bancorp increased its Day One Biopharmaceuticals (DAWN) stake by 57% in Q1 2026, buying an estimated $2.11K and bringing the position to 414 shares worth $8.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

US Bancorp first reported a position in DAWN in Q1 2023 and has held it in 7 quarters since. The position peaked at $298K in Q1 2023. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • US Bancorp held 414 shares of Day One Biopharmaceuticals worth $8.88K as of Q1 2026.
  • US Bancorp bought 150 Day One Biopharmaceuticals shares in Q1 2026, an estimated $2.11K.
  • Day One Biopharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3393 holding.
  • US Bancorp first reported a position in Day One Biopharmaceuticals in Q1 2023 and has held it in 7 quarters since.
  • US Bancorp's Day One Biopharmaceuticals position peaked at $298K in Q1 2023.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.